Samson Rock Capital’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Samson Rock Capital’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-467,072	Closed	-$15.8M	–	89
2021 Q2	$15.8M	Buy	+467,072	New	+$11.9M	3.11%	10

Samson Rock Capital's CNST Position: Q3 2021 in Review

Samson Rock Capital sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 467,072 shares — an estimated $15.8M sold.

Samson Rock Capital first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $15.8M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Samson Rock Capital reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Samson Rock Capital sold 467,072 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $15.8M.
Samson Rock Capital first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
Samson Rock Capital's Constellation Pharmaceuticals, Inc. position peaked at $15.8M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Samson Rock Capital's 13F filing for Q3 2021, filed 18 Oct 2021.